Precision NextGen Oncology & Research Center

Beverly Hills, California 90212

5 studies enrolling now · 8 studies all time

What they study most

Advanced Solid Tumors, Breast Cancer, Breast Cancer Stage IV, Breast Neoplasm, CNS Tumor, Cancer, Cancer Harboring BRAF Alterations, Cholangiocarcinoma, Conventional Chondrosarcoma, Endometrial Cancer, HGG, LGG

Studies at this site

• A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations — Recruiting now
• A Study of PHST001 in Advanced Solid Tumors — Recruiting now
• A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors — Recruiting now
• Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors — Recruiting now
• A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer — Recruiting now
• Study of INBRX-109 in Conventional Chondrosarcoma — Running, not enrolling
• Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo) — Running, not enrolling
• A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors — Enrolling by invitation